EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease

Kaung H T Salai iD, Liu-Yun Wu iD, Joyce R Chong, Yuek Ling Chai, Bibek Gyanwali, Caroline Robert iD, Saima Hilal, Narayanaswamy Venketasubramanian iD, Gavin S Dawe iD, Christopher P Chen, Mitchell K P Lai iD

Biomolecules · 13.03.2023 · 13 (3) · 525

DOI: 10.3390/biom13030525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 13.03.2023. Verfasst von Kaung H T Salai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Cerebral Small Vessel Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University Health System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor-receptor 1 (TNF-R1)-mediated signaling is critical to the regulation of inflammatory responses. TNF-R1 can be proteolytically released into systemic blood circulation in a soluble form (sTNF-R1), where it binds to circulating TNF and functions to attenuate TNF-mediated inflammation. Increases of peripheral sTNF-R1 have been reported in both Alzheimer’s disease (AD) dementia and vascular dementia (VaD). However, the status of sTNF-R1 in predementia subjects (cognitive impairment, no dementia, CIND) is unknown, and putative associations with cerebral small vessel disease (CSVD), as well as with longitudinal changes in cognitive functions are unclear. We measured baseline serum sTNF-R1 in a longitudinally assessed cohort of 93 controls and 103 CIND, along with neuropsychological evaluations and neuroimaging assessments. Serum sTNF-R1 levels were increased in CIND compared with controls (p < 0.001). Higher baseline sTNF-R1 levels were specifically associated with lacunar infarcts (rate ratio = 6.91, 95% CI 3.19–14.96, p < 0.001), as well as lower rates of cognitive decline in the CIND subgroup. Our data suggest that sTNF-R1 interacts with vascular cognitive impairment in a complex manner at predementia stages, with elevated levels associated with more severe CSVD at baseline, but which may subsequently be protective against cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type ICerebral Small Vessel DiseasesHumansReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Alzheimer’s diseaseTNF-receptor 1biomarkercerebral small vessel diseasespredementiaserumtumor necrosis factorvascular cognitive impairment

Substanzen

Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
  • Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.
  • Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117597, Singapore.
  • Departments of Epidemiology and Radiology & Nuclear Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Raffles Neuroscience Centre, Raffles Hospital, Singapore 188770, Singapore.

ORCID-Profile: Kaung H T Salai, Liu-Yun Wu, Caroline Robert, Narayanaswamy Venketasubramanian, Gavin S Dawe, Mitchell K P Lai

Förderung

  • National Medical Research Council
  • Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine
  • National University Health System
  • Yong Loo Lin School of Medicine
  • Singapore Ministry of Education

Zitieren

APA

Salai, K. H. T., Wu, L. Y., Chong, J. R., Chai, Y. L., Gyanwali, B., Robert, C., Hilal, S., Venketasubramanian, N., Dawe, G. S., Chen, C. P., & Lai, M. K. P. (2023). Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease. Biomolecules, 13(3), 525. https://doi.org/10.3390/biom13030525

Vancouver

Salai KHT, Wu LY, Chong JR, Chai YL, Gyanwali B, Robert C, et al. Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease. Biomolecules. 2023;13(3):525. doi:10.3390/biom13030525

BibTeX
@article{Salai2023,
  author = {Salai, Kaung H T and Wu, Liu-Yun and Chong, Joyce R and Chai, Yuek Ling and Gyanwali, Bibek and Robert, Caroline and Hilal, Saima and Venketasubramanian, Narayanaswamy and Dawe, Gavin S and Chen, Christopher P and Lai, Mitchell K P},
  title = {Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {525},
  doi = {10.3390/biom13030525}
}
Kostenlos starten →